ETFMG Treatments, Testing and Advancements ETF
Limited financial coverage for GERM.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
This fund aims to replicate the investment performance of U. S. -listed companies, including equity shares and depositary receipts, that are primarily engaged in two sectors: either researching, developing, and bringing to market treatments or vaccines for infectious diseases, or producing, researching, and supplying biological diagnostic tests for patients.
- IPO
- 2020
- HQ
- DE, US
Price Chart
- 52W High
- $20.20
- 52W Low
- $16.32
- 50D MA
- $18.93
- 200D MA
- $18.53
- Beta
- 1.02
- Avg Volume
- 1.20K
Get TickerSpark's AI analysis on GERM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our GERM coverage
Recent articles, reports, and earnings notes.
No research on GERM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GERM report →Similar companies
Peers in the same neighborhood.